Genus Power: Guidance - The company expects net debt to peak at approximately INR1,900 crores to INR2,000 crores, up from INR1,573 crore as of March '26, with reductions starting from FY '28 onwards. - Concall Update

Genus Power: Guidance - No major CapEx is planned for FY '27, only regular CapEx of INR10 crores to INR20 crores for items like dies and molds. || Working capital days are expected to improve by another 50 to 75 days in the current year, following a reduction from 343 days in March '25 to 274 days in March '26. - Concall Update

Genus Power: Guidance - Management expects FY '27 revenue between INR6,000 crore and INR6,500 crore, driven by increased rollout intensity and conversion of the order book. || For FY '27, the EBITDA margin guidance is 18%, a reduction of 2% to 2.5% from FY '26, due to anticipated surges in raw material prices from war, petroleum, and chip costs. - Concall Update

Afcons Infra: Guidance - The CapEx for FY27 is projected to be around INR725 crores. || Management expects a sizable drop in debt for FY27 and aims to reduce working capital days to around 120, with approximately INR1,000 crores of receivables expected to be unlocked by June. - Concall Update

Afcons Infra: Guidance - The order booking guidance for FY27 is INR30,000 crores, with INR15,000 crores having clear visibility, including L1 orders, and the remaining INR15,000 crores also having definitive visibility. - Concall Update

Afcons Infra: Guidance - Management is not providing specific revenue growth or EBITDA margin guidance for FY27 due to continued geopolitical uncertainty, elongated award cycles, and ongoing project developments. - Concall Update

Zydus Life: Expects FY27 EBITDA Margins To Go Beyond 24%, Considering Competition From Mirabegron And Launch Expenses For Saro, With R&D Costs Estimated Over 8%. The Biosimilars Business In India Is A Significant Contributor, Surpassing INR 800 Crores, And Global Expansion Is Anticipated By FY29-30.

Zydus Life: Plans To Invest INR 70 Million For Saro Commercialization And A Total Capex Of About INR 1,500 Crore For FY27, With Quarterly Depreciation Estimated At INR 550 Crore. Management Anticipates India's Business Will Surpass Market Growth By 200 To 400 Basis Points In FY27.

Zydus Life: Expects Strong Growth In International Markets And Consumer Wellness, With EBITDA Margin Projected Over 24% For FY27 Despite Competition And Saro Launch Costs.

GPT Healthcare: Guidance - Jamshedpur Hospital, a 150-bed facility, is expected to be commissioned by Q4 FY '27 with a CapEx of approximately INR 70 lakhs per bed, following a similar ramp-up trend as Raipur. || Occupancy targets for FY '27 include Salt Lake at 70-73%, Dum Dum at 72-78%, Agartala moving towards 58%, and Howrah reaching the late 50s. - Concall Update

Zydus Life: Expects Consolidated Revenue To Grow In The High Teens For FY27. North American Business Anticipated To Grow In The Single Digits, While India's Branded Formulations Projected To Exceed Market Growth By 200 To 400 Basis Points.

GPT Healthcare: Guidance - The Raipur Hospital is projected to reach a monthly operational breakeven by Q3 FY '27, closing the year at around 30% occupancy, with a slight full-year loss before becoming fully positive next year. - Concall Update

GPT Healthcare: Guidance - The company anticipates ARPOB to grow by approximately 8% in FY '27 due to tariff increases and specialty optimization, with Agartala's ARPOB increasing by 7% to 8% but remaining lower than Kolkata units. - Concall Update

GPT Healthcare: Guidance - For FY27, GPT Healthcare expects overall revenue to increase by 15% year-over-year, with EBITDA margin growing by approximately 100 basis points to around 20.2%. - Concall Update

GNFC: Guidance - Ammonia expansion, weak nitric acid, and ammonium nitrate melt plants are all expected to come online by next year (FY27), though weak nitric acid has a minor delay of approximately 2.5 months. || Management does not foresee the fertilizer segment, specifically urea, turning positive until fixed cost and energy norms are revised, as losses are currently widening. - Concall Update

GNFC: Guidance - The coal-based CCPP is expected to synchronize by the third week of June and be fully operational by the third week of August 2026, with an estimated saving potential of INR 10-12 crore per month accruing from H2 FY27. - Concall Update

GNFC: Guidance - Management expects to finalize new project identification for investment decisions by the end of the current calendar year. || The CapEx for FY27 is projected to be around INR 2,800 crores, with details for FY28 to be provided in subsequent quarters. - Concall Update